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Widespread mosaicism
Although the ability to generate induced pluripotent stem cells 
(iPSCs) from somatic cells has revolutionized the field of regen-
erative medicine, reports of genomic instability in stem and pre-
cursor cells suggest that these iPSCs may harbor copy-number 
variations (CNVs) in addition to single-base-pair changes. To 
examine this possibility, Abyzov and colleagues recently uti-
lized next-generation sequencing to facilitate whole-genome 
and transcriptome analysis of 20 human iPSC lines generated 
from fibroblasts. On average, the iPSC lines contained two 
CNVs; interestingly, 50% of the CNVs were found as low-
frequency somatic genomic variants in the original parental 
fibroblasts. Thus, these iPSC lines exhibited genomic stability, 
and the presence of the variants in the parental cells supports 
widespread somatic mosaicism for CNV in the genomes of the 
fibroblasts. On the assumption that each iPSC colony represents 
a single clone, the authors estimate that 30% of skin fibroblasts 
contain large somatic CNVs. If this estimate is validated, these 
findings will challenge the basis for genetic disease analysis. 
(Nature 492:438–42, 2012) Selected by S. Yuspa
Next-generation disease investigation
Technical advances in next-generation sequencing offer oppor-
tunities to identify gene mutations in unresolved cases of many 
diseases, including the inherited skin fragility disorders col-
lectively termed epidermolysis bullosa. McGrath and col-
leagues recently employed whole-exome sequencing of three 
siblings with skin fragility to identify a homozygous 1-bp dele-
tion (c.5786delC) in EXPH5, the gene that encodes the Rab27B 
GTPase effector protein Slac2-b. Sanger sequencing confirmed 
the presence and segregation of this mutation in the family. This 
frameshift mutation results in premature termination and trun-
cation of the 1,989-amino-acid Slac2-b protein by 52 residues. 
Although RT-PCR demonstrated expression of EXPH5 mRNA 
in affected subjects and controls, immunohistochemical stain-
ing revealed a complete absence of this protein in patient skin 
samples. Furthermore, keratin filaments were disrupted in both 
patient and Slac2-b knockdown keratinocytes, supporting a role 
for Slac2-b in maintaining keratinocyte integrity and thus in pre-
venting skin fragility. These exciting findings expand the clinico-
pathological spectrum of epidermolysis bullosa and highlight the 
utility of whole-exome sequencing in unraveling disease etiol-
ogy. (Am J Hum Genet 91:1115–21, 2012) Selected by K. Green
Cellular sprayground
Standard treatment with infection control, primary dress-
ings, and high-strength compression results in healing of only 
30–75% of venous leg ulcers. Kirsner and colleagues explored 
the effectiveness of a previously developed spray-applied cell 
therapy with cryopreserved human allogeneic, growth-arrested 
fibroblasts and keratinocytes from neonatal foreskin (HP802-
247) for the treatment of venous leg ulcers in a phase II, mul-
ticenter, double-blind, randomized, placebo-controlled trial of 
205 patients. Treatment resulted in enhanced wound closure, 
reduced healing time, and a larger proportion of closed wounds 
as compared with vehicle alone or with reported effects of 
standard treatments. The group that received 0.5 × 106 cells/ml 
every 14 days exhibited the best results, with minimal adverse 
events. These promising results highlight the need for larger ran-
domized trials that directly compare this sprayed-cell technique 
with standard treatment for venous leg ulcers. (Lancet 380:977–
85, 2012) Selected by T. Nijsten
Strategic location
Approximately 20 billion T cells reside in human skin, and near-
ly all of these are skin-homing memory T cells. Skin-resident 
Langerhans cells (LCs) are poised to interact with these mem-
ory T cells in the skin; however, the physiological role of LCs 
with respect to immunoregulation versus immunostimulation 
remains controversial. Seneschal and colleagues recently dem-
onstrated that LCs induced CD4+CD25+FoxP3+CD127− skin-
resident regulatory T cells (Tregs) to proliferate. These memory 
Tregs were located within or near the epidermis or follicular 
epithelium—sites that are proximal to LCs. Importantly, patho-
genic antigen exposure to Candida albicans resulted in LC 
induction of pathogen-specific effector memory T cells as well 
as Tregs. Thus, the biological context dictates the function of LCs 
in maintaining peripheral tolerance or activating protective skin-
resident memory T cells to mount an effective host response. 
(Immunity 36:873–4, 2012) Selected by S. Hwang
Beyond antibody replacement
In a recent thought-provoking review, Erwin Gelfand described 
the use of intravenous immune globulin in autoimmune and 
inflammatory diseases. Despite the introduction of many new 
biologics to combat inflammation and autoimmunity, immune 
globulin treatment, which was developed in the 1950s, remains 
not only a lifesaving treatment for patients with antibody 
deficiency but also an important treatment for those with 
blistering skin disease, transplant rejection, neurologic disease, 
and other inflammatory and autoimmune diseases. Effects on 
various effector cell types, cytokines, chemokines, and other 
mediators have been ascribed to this agent, but it remains to be 
seen whether a single mechanism of action underlies the varied 
effects of intravenous immune globulin. Doses for autoimmune 
and inflammatory disease treatments are often four to five times 
greater than those used to treat immunodeficiency; thus, future 
studies to decipher the mechanism of action of this treatment in 
order to eventually replicate the specific effector are necessary 
to meet the demand for this biologic. (N Engl J Med 367:2015–
25, 2012) Selected by B. Gilchrest
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